Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1–7 Signals
Open Access
- 19 May 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Biological Trace Element Research
- Vol. 201 (4), 1846-1863
- https://doi.org/10.1007/s12011-022-03286-4
Abstract
Cadmium (Cd) is a serious pollutant in the environment. Candesartan is an angiotensin II (Ang II) receptor antagonist with promising diverse health benefits. The current study is planned to investigate the hepatorenal protective effects of candesartan against Cd-induced hepatic and renal intoxication. Our results demonstrated that candesartan effectively attenuated Cd-induced hepatorenal intoxication, as evidenced by improving hepatic and renal function biomarkers. Besides, candesartan reversed hepatic and renal histopathological abrasions induced by Cd toxicity. Candesartan antioxidant effect was mediated by Nrf2 activation. Also, candesartan suppressed hepatorenal inflammation by modulating NF-κB/IκB. Moreover, candesartan attenuated Cd hepatorenal apoptosis by upregulating Bcl-2 and downregulating Bax and Cyt-C proteins. Interestingly, these effects are suggested to be an outcome of modulating of Ang II/Ang 1–7 signal. Overall, our findings revealed that candesartan could attenuate Cd-induced hepatorenal intoxication through modulation of Nrf2, NF-κB/IκB, Bax/Bcl-2/Cyt-c, and Ang II/Ang 1–7 signaling pathways.Keywords
Funding Information
- Al-Azhar University
This publication has 57 references indexed in Scilit:
- Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in miceNephrology, 2010
- Testis response to low doses of cadmium in Wistar ratsInternational Journal of Experimental Pathology, 2010
- Cadmium, Environmental Exposure, and Health OutcomesEnvironmental Health Perspectives, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockadeKidney International, 2008
- Angiotensin II and oxidative stressCurrent Opinion in Cardiology, 2007
- CandesartanCardiovascular Drug Reviews, 2004
- Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat: The effect of AT1-R blocker on the hepatic fibrosisExperimental and Toxicologic Pathology, 2003
- Sublethal effects of the (Exxon Valdez) oil spill on herring embryos and larvae: morphological, cytogenetic, and histopathological assessments, 1989–1991Canadian Journal of Fisheries and Aquatic Sciences, 1996
- Immunoassay using antigen—enzyme conjugatesFEBS Letters, 1971